📣 VC round data is live. Check it out!

Cigna Group Valuation Multiples

Discover revenue and EBITDA valuation multiples for Cigna Group and similar public comparables like Munich Re, Generali, Elevance Health, Travelers and more.

Cigna Group Overview

About Cigna Group

Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.


Founded

1981

HQ

United States

Employees

67.7K

Financials (LTM)

Revenue: $279B
EBITDA: $13B

EV

$99B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Cigna Group Financials

Cigna Group reported last 12-month revenue of $279B and EBITDA of $13B.

In the same LTM period, Cigna Group generated $24B in gross profit, $13B in EBITDA, and $8B in net income.

Revenue (LTM)


Cigna Group P&L

In the most recent fiscal year, Cigna Group reported revenue of $244B and EBITDA of $9B.

Cigna Group is profitable as of last fiscal year, with EBITDA margin of 4% and net margin of 1%.

See analyst estimates for Cigna Group
LTMLast FY202320242025202620272028
Revenue$279B$244B$195B$244B$275B
Gross Profit$24B———$26B
Gross Margin9%———9%
EBITDA$13B$9B$10B$9B$13B
EBITDA Margin5%4%5%4%5%
EBIT Margin4%———3%
Net Profit$8B$3B$5B$3B$8B
Net Margin3%1%3%1%3%
Net Debt—$24B———

Financial data powered by Morningstar, Inc.

Cigna Group Stock Performance

Cigna Group has current market cap of $75B, and enterprise value of $99B.

Market Cap Evolution


Cigna Group's stock price is $285.27.

Cigna Group share price decreased by 1.8% in the last 30 days, and by 9.9% in the last year.

Cigna Group has an EPS (earnings per share) of $12.98.

See more trading valuation data for Cigna Group
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$99B$75B-3.3%-1.8%-1.6%-9.9%$12.98

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Cigna Group Valuation Multiples

Cigna Group trades at 0.4x EV/Revenue multiple, and 7.7x EV/EBITDA.

See NTM and 2027E valuation multiples for Cigna Group

EV / Revenue (LTM)


Cigna Group Financial Valuation Multiples

As of May 16, 2026, Cigna Group has market cap of $75B and EV of $99B.

Cigna Group has a P/E ratio of 9.4x.

LTMLast FY202320242025202620272028
EV/Revenue0.4x0.4x0.5x0.4x0.4x
EV/EBITDA7.7x10.4x9.9x10.4x7.8x
EV/EBIT9.9x———10.3x
EV/Gross Profit4.1x———3.9x
P/E9.4x22.0x14.6x22.0x9.4x
EV/FCF11.2x11.0x9.6x11.0x11.7x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Cigna Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Cigna Group Margins & Growth Rates

Cigna Group grew revenue by 12% and EBITDA by 33% in the last fiscal year.

In the most recent fiscal year, Cigna Group reported EBITDA margin of 4% and net margin of 1%.

See estimated margins and future growth rates for Cigna Group

Cigna Group Margins

Last FY202420252026202720282029
Gross Margin——9%7%
EBITDA Margin4%4%5%5%
EBIT Margin——3%4%
Net Margin1%1%3%3%
FCF Margin4%4%3%3%

Cigna Group Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth12%25%12%4%
Gross Profit Growth———(18%)
EBITDA Growth33%(5%)33%4%
EBIT Growth———11%
Net Profit Growth133%(34%)133%(0%)
FCF Growth(4%)(13%)(6%)8%

Data powered by FactSet, Inc. and Morningstar, Inc.

Cigna Group Operational KPIs

Cigna Group's revenue per employee in the last FY averaged $3.6M.

Cigna Group's Rule of 40 is 8% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Cigna Group's Rule of X is 13% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for Cigna Group
LTMLast FY202620272028
Rule of 409%8%
Bessemer Rule of X15%13%
Revenue per Employee—$3.6M

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Cigna Group Competitors

Cigna Group competitors include Munich Re, Generali, Elevance Health, Travelers, Manulife, Aflac, Tokio Marine, AXA, Allstate and Life Insurance Corporation of India.

Most Cigna Group public comparables operate across Insurance Carriers and Health Benefits & Financial Solutions.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Munich Re—1.0x—7.5x
Generali0.9x0.9x11.8x11.4x
Elevance Health0.5x0.5x11.1x11.3x
Travelers1.5x1.6x8.8x8.9x
Manulife1.5x2.5x14.5x14.0x
Aflac3.9x4.0x13.2x13.5x
Tokio Marine1.5x1.6x9.0x9.2x
AXA1.0x1.2x10.6x10.6x

This data is available for Pro users. Sign up to see all Cigna Group competitors and their valuation data.

Start Free Trial

Cigna Group M&A Activity

Cigna Group has acquired 3 companies to date.

Last acquisition by Cigna Group was on March 8th 2018. Cigna Group acquired Express Scripts for $67B (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by Cigna Group

Express Scripts
Brighter.com
Zurich Insurance Middle East
Description
Express Scripts is a pharmacy benefit manager serving the United States and Canada as a Cigna subsidiary. Headquartered in St. Louis, Missouri, since its 2012 formation from Aristotle Holding founded in 1986, it manages drug formularies, home delivery through 10 automated and specialty pharmacies, and a retail network of 57,000-plus locations. The company administers benefits for 100 million members, including Medicare and Medicaid plans, with services like SafeGuardRx for high-cost therapies.
Brighter is a consumer health platform connecting patients, providers, and payers for dental benefits administration. Its web and mobile apps enable transparent provider search, cost comparisons, and claims processing for self-insured employers. Mountain View-headquartered since 2010, Brighter licenses technology to insurers handling fully-insured plans. The system reduces administrative costs through market-driven pricing and engagement tools.
Zurich Insurance Middle East is a Beirut-headquartered insurer operating in the UAE, Lebanon, and Jordan that underwrites motor, home, travel, life, cargo, casualty, employee benefits, property, and energy insurance for individuals and businesses. Rebranded from Compagnie Libanaise D'Assurances in 2011, the company maintains agencies in Dubai and Amman, partnering with regional brokers for commercial risk transfer.
HQ CountryUnited StatesUnited StatesLebanon
HQ City
Mount Pleasant, SC
Los Angeles, CA
Beirut
Deal Date8 Mar 201814 Dec 201711 Jul 2017
Valuation$67Bundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Cigna Group acquisitions and their M&A valuation multiples.

Start Free Trial

Cigna Group Investment Activity

Cigna Group has invested in 4 companies to date.

Latest investment by Cigna Group was on May 4th 2023. Cigna Group invested in Prognos Health in their $23M Undisclosed stage round (EV/Revenue multiple of ).

See VC round multiples

Latest Investments by Cigna Group

Prognos Health
Ryse Health
MDLIVE
Prognos Health
Description
Prognos Health is a New York-based healthcare analytics platform querying de-identified records from over 325 million patients. Its prognosFACTOR tool analyzes lab results and claims data for pharmaceutical cohort identification and patient journey mapping. Prognos serves 25 of the top 30 pharma companies and major payers like UnitedHealth.
Ryse Health is a virtual care platform focused on diabetes management for patients and families. The service delivers therapeutics, daily coaching, analytics, and access to endocrinologists plus care teams through in-person and telehealth visits. Arlington, Virginia-headquartered since its 2021 founding, Ryse Health employs connected glucose meters and medication delivery to improve adherence and outcomes like A1C reduction. The platform serves individuals nationwide with personalized plans addressing nutrition, exercise, and behavioral support.
MDLIVE is a telehealth provider delivering on-demand virtual care, behavioral health, and chronic condition management through app, web, and phone. Headquartered in Jacksonville, Florida, and acquired by Cigna in 2021, the platform serves 57 million members via employer, payer, and hospital partnerships, conducting 10 million visits annually.
Prognos Health is a New York-based healthcare analytics platform querying de-identified records from over 325 million patients. Its prognosFACTOR tool analyzes lab results and claims data for pharmaceutical cohort identification and patient journey mapping. Prognos serves 25 of the top 30 pharma companies and major payers like UnitedHealth.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
New York City, NY
Washington, DC
Pensacola, FL
New York City, NY
Deal Date4 May 20238 Apr 20221 Aug 201827 Nov 2017
RoundUndisclosed stageSeedUndisclosed stageSeries C
Raised$23M$3M$50M$21M
InvestorsCigna Group; Hikma Ventures; Hunt Companies; Labcorp; Marshall Wace; Maywic Select Investments; Merck; Red & Blue Ventures; Safeguard ScientificsBlue Shield of California; Boston Children's Hospital; CareFirst; Cigna Group; Healthworx; John Wray; Kelly Close; LifeBridge Health; Shantanu Agarwal; W Health VenturesCigna Group; Health Care Service Corporation; Health Velocity Capital; Industry Ventures; Novo HoldingsCigna Group; Guardian Life; Hermed Capital; Hikma Ventures; Maywic Select Investments; Merck Global Health Innovation Fund; Safeguard Scientifics
Valuationundisclosedundisclosedundisclosedundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Cigna Group investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Cigna Group

When was Cigna Group founded?Cigna Group was founded in 1981.
Where is Cigna Group headquartered?Cigna Group is headquartered in United States.
How many employees does Cigna Group have?As of today, Cigna Group has over 67K employees.
Who is the CEO of Cigna Group?Cigna Group's CEO is David M. Cordani.
Is Cigna Group publicly listed?Yes, Cigna Group is a public company listed on NYSE.
What is the stock symbol of Cigna Group?Cigna Group trades under CI ticker.
When did Cigna Group go public?Cigna Group went public in 1982.
Who are competitors of Cigna Group?Cigna Group main competitors include Munich Re, Generali, Elevance Health, Travelers, Manulife, Aflac, Tokio Marine, AXA, Allstate, Life Insurance Corporation of India.
What is the current market cap of Cigna Group?Cigna Group's current market cap is $75B.
What is the current revenue of Cigna Group?Cigna Group's last 12 months revenue is $279B.
What is the current revenue growth of Cigna Group?Cigna Group revenue growth (NTM/LTM) is 4%.
What is the current EV/Revenue multiple of Cigna Group?Current revenue multiple of Cigna Group is 0.4x.
Is Cigna Group profitable?Yes, Cigna Group is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of Cigna Group?Cigna Group's last 12 months EBITDA is $13B.
What is Cigna Group's EBITDA margin?Cigna Group's last 12 months EBITDA margin is 5%.
What is the current EV/EBITDA multiple of Cigna Group?Current EBITDA multiple of Cigna Group is 7.7x.
What is the current FCF of Cigna Group?Cigna Group's last 12 months FCF is $9B.
What is Cigna Group's FCF margin?Cigna Group's last 12 months FCF margin is 3%.
What is the current EV/FCF multiple of Cigna Group?Current FCF multiple of Cigna Group is 11.2x.
How many companies Cigna Group has acquired to date?As of May 2026, Cigna Group has acquired 3 companies.
What was the largest acquisition by Cigna Group?$67B acquisition of Express Scripts on 8th March 2018 was the largest M&A Cigna Group has done to date.
What companies Cigna Group acquired?Cigna Group acquired Express Scripts, Brighter.com, and Zurich Insurance Middle East.
In how many companies Cigna Group has invested to date?As of May 2026, Cigna Group has invested in 4 companies.
What was the last Cigna Group investment?On 4th May 2023 Cigna Group invested in Prognos Health, participating in a $23M Undisclosed stage round, alongside Hikma Ventures, Hunt Companies, Labcorp, Marshall Wace, Maywic Select Investments, Merck, Red & Blue Ventures, and Safeguard Scientifics.
In what companies Cigna Group invested in?Cigna Group invested in MDLIVE, Omada Health, Prognos Health, and Ryse Health.

See public comps similar to Cigna Group

Lists including Cigna Group

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial